Privacyvoorkeur

MEDtalks houdt u graag op de hoogte van de laatste ontwikkelingen op uw interessegebied. Kies hieronder of u op de hoogte gehouden wilt blijven van de nieuwste programma's en nascholingen binnen uw interessegebieden. Klik hier voor meer informatie.


Zoekresultaten voor tag ISTH
Congresnieuws 22/07/2013

ISTH 2013: Journal | Gene therapy

In dit journaal vanaf de ISTH 2013, aandacht voor Gene therapy: Update on AAV- mediated gene therapy for hemophilia B Gene therapy: state of the art

Congresnieuws 22/08/2011

ISTH News | hemophilia and cancer

Round Table number 1 from the ISTH in Kyoto. In an interactive session, moderator dr. Evert-Jan de Kruijf discusses several aspects of cancer in hemophilia patients with his guests, professor Ingrid Pabinger and professor Cedric Hermans. Both the incidence of cancer and the management of cancer in hemophilia are topics of this Round Table program.

Congresnieuws 22/08/2011

ISTH News | inhibitors in hemophilia

Round Table number 2 from the ISTH in Kyoto: What are inhibitors? What do we know about riskfactors for developing an inhibitor in hemophilia patients? How does the Rodin study unravel the influence of early prophylaxis, intensive treatment and other factors on inhibitor development? These and other questions are answered in a lively Round Table, moderated by dr. Evert-Jan de Kruijf, hematologist from the Netherlands. His guests are dr. Marijke van den Berg and dr Johanna van der Bom, principal investigators of the Rodin study.